Trial
NCT04437368
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Gyroscope Therapeutics Limited
Collaborators
Novartis Pharmaceuticals
Condition
Dry Age-related Macular Degeneration
Intervention
GT005
Why stopped
Terminated for interim analysis demonstrating futility (trial highly unlikely to meet efficacy outcome). The trial is not ending early because of medical problems or concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-27